May 22, 2024 | Featured, Maryland, News, Science
InGel Therapeutic’s emerging, innovative cellular treatment for preserving cone-mediated vision in people with retinitis pigmentosa (RP), Usher syndrome, and potentially other retinal conditions, was presented by Deepti Singh, PhD, InGel’s co-founder and chief...
May 16, 2024 | Featured, Maryland, News, Science
PYC Therapeutics, an Australia-based developer of RNA therapies, reported initial results from its Phase 1 PLATYPUS clinical trial in the US for an RNA therapy known as VP-001 for people with retinitis pigmentosa 11 (RP11) which is caused by mutations in the gene...